Markets continued to trade with negative bias in late noon trades weighed down by export-led pharma and IT shares along with select index heavyweights.
At 2:30PM, the Sensex was down by 12 points or 0.05% at 26,511 and the Nifty was down by 15 points or 0.18% at 8,029.
The broader markets, however, are underperforming their larger counterparts with BSE Midcap and Smallcap indices down by 0.3% each. The market breadth is weak with 1,510 declines against 981 advances on the BSE.
Meanwhile, according to Moody, a weak monsoon is likely to be credit-negative for India as it is expected to push up food inflation as well as government deficits. Further, IMD has revised its monsoon forecast for 2015 from below normal to deficit.
The Indian rupee was trading higher at Rs 63.89 against the US dollar, appreciating by 19 paise amid fresh dollar selling by exporters and banks.
SECTORS & STOCKS
On the sectoral front, BSE Healthcare index is leading the decline as it down by 1.2% while Metal index is the top gainer up by nearly 1%, thus capping the losses.
Vedanta surged over 3.5% and is the top gainer on the Sensex. Cairn India is likely to merge with Vedanta, which will give a debt-heavy Vedanta an access to Cairn India’s cash. The fear of a possible merger has affected Cairn India, a listed oil and gas producing company whose shares dipped over 4.5% on the BSE.
Trade unions representing workers of Tata Steel in the UK will go on strike on June 22 over proposed changes to the company's pension scheme. Shares of Tata steel advanced on the Sensex and is trading 1.3% up on account of profit –booking.
Banking shares gained ground after the central bank in an announcement today, allowed banks to take control of debt-laden companies by converting loans into equity, if a debt restructuring fails to revive them within a stipulated timeframe. Shares of Axis Bank, ICICI Bank, and SBI have gained between 0.5-1.1% each on the Sensex.
HDFC was up nearly 1% on BSE after the largest mortgage lender approved fund-raising worth Rs 5,000 crore simultaneously by secured redeemable non-convertible debentures (NCDs) and warrants.
Other notable gainers are Hindalco, Hindustan Unilever, Tata Motors, all gaining more than 1.5% on the Sensex.
On the flip side, Cipla is the leading loser on the Sensex after shares of drug maker have dropped 2.2% and on worries of earnings been affected after its peer Mylan launched an asthma drug in UK which was earlier expected to be launched by Cipla.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)